Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection
Clinical trial NCT04348513 · TERMINATED
Trial details
- NCT number
- NCT04348513
- Sponsor
- Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-29
- Primary completion
- 2021-04-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.